Skip to content

Using Cardiopulmonary Exercise Test as an Incentive to Outpatient Cardiac Rehabilitation for Acute Coronary Syndrome Survivors.

Cardiopulmonary Exercise Test as an Incentive to Outpatient Cardiac Rehabilitation for Acute Coronary Syndrome Survivors

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05401240
Enrollment
200
Registered
2022-06-02
Start date
2023-09-01
Completion date
2026-07-30
Last updated
2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome

Keywords

cardiac rehabilitation, cardiopulmonary exercise testing

Brief summary

Exercise-based cardiac rehabilitation is a class I recommendation for acute coronary syndrome (ACS) patients. However, participate rate of outpatient rehabilitation is quite low and remains a global issue. The study is to propose a strategy in order to encourage post-ACS patients to participate in the outpatient cardiac rehabilitation.

Detailed description

Background: exercise-based cardiac rehabilitation is a class I recommendation for acute coronary syndrome (ACS) patients. However, participate rate of outpatient rehabilitation is quite low and remains a global issue. The study is to propose a strategy in order to encourage post-ACS patients to participate in the outpatient cardiac rehabilitation. Hypothesis: cardiopulmonary exercise test (CPET) incentives ACS survivors to participate in outpatient cardiac rehabilitation. Objectives: 200 ACS survivors who are eligible for cardiac rehabilitation will be allocated randomly into control and experimental groups. Method: before discharge, both control and experimental groups will be informed of the importance of cardiac rehabilitation and invited to participate the outpatient rehabilitation. The experimental group will also be told that an important examination, i.e. the CPET, will be performed in order to evaluate their heart function at the outpatient department (OPD). Primary outcome: the presence of ACS survivors at the OPD of rehabilitation in order to receive the rehabilitation/CPET. Secondary outcomes: the adherence to cardiac rehabilitation, defined as completing a full course of cardiac rehabilitation (6 sessions) or home-based exercise. Factors that might influence the presence of ACS survivors at OPD of rehabilitation will also be recorded and analyzed, including: * Patient characteristics: age, sex, body mass index (BMI), cardiovascular disease (CVD) risk factors * Electrocardiography (ECG): ST elevation myocardial infarction (STEMI) or non ST elevation myocardial infarction (NSTEMI) * Lab data: peak troponin level. * Days of hospitalization. Statistics: t-test, ANOVA

Interventions

BEHAVIORALinformation reveal

the experimental group will be informed that there will be an important examination about his/her cardiopulmonary fitness condition at the outpatient department (OPD)

Sponsors

Taichung Veterans General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* acute coronary patients

Exclusion criteria

* acute illness that stayed in hospital for more than 2 weeks. * patients who received surgical intervention * severe complications (ex. respiratory failure, stroke, acute renal failure) * contraindications of cardiopulmonary exercise testing * patients who cannot perform the cardiopulmonary exercise testing

Design outcomes

Primary

MeasureTime frameDescription
the return ratescheduled appointment time, about 2 to 4 weeks after dischargepatient that did return to the OPD for examination and cardiac rehabilitation

Secondary

MeasureTime frameDescription
the adherence6 months after dischargethe percentage of patients that keep taking cardiac rehabilitation for more than one session

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026